{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:04:37Z","timestamp":1790665477151,"version":"4.1.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Senior Clinical Dekker"},{"name":"Dutch Heart Foundation","award":["2021T055"],"award-info":[{"award-number":["2021T055"]}],"id":[{"id":"https:\/\/ror.org\/05nxhgm70","id-type":"ROR","asserted-by":"crossref"}]},{"name":"ZONMW-VIDI","award":["09150172210019"],"award-info":[{"award-number":["09150172210019"]}]},{"name":"Senior Scientist Dekker","award":["03-004-2021-T045"],"award-info":[{"award-number":["03-004-2021-T045"]}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","award":["101076407"],"award-info":[{"award-number":["101076407"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","award":["09150172310053"],"award-info":[{"award-number":["09150172310053"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Dutch Kidney and Dutch Diabetes Foundation"},{"name":"NWO VICI","award":["09150182010020"],"award-info":[{"award-number":["09150182010020"]}]},{"name":"ERC Advanced","award":["101141346"],"award-info":[{"award-number":["101141346"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>Glucagon-like peptide-1 receptor agonists (GLP-1RAs) reduce cardiovascular disease (CVD) in type 2 diabetes (T2D) and have anti-inflammatory effects in experimental studies, but their mechanism of action in humans remains unclear. This study characterized the cardiovascular\u2013haematopoietic axis in individuals with T2D receiving semaglutide, as a potential mediator of GLP-1RA cardioprotective properties.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In 16 individuals with T2D [63.2 \u00b1 6.1 years, 37.5% female, weight 82.3 \u00b1 15.3\u2005kg, body mass index (BMI) 28.33 \u00b1 3.5\u2005kg\/m2, LDL cholesterol 2.2 \u00b1 0.9\u2005mmol\/L, glycated haemoglobin (HbA1c) 78.1 \u00b1 13.1\u2005mmol\/mol, high-sensitivity C-reactive protein (hsCRP) 1.9 (1.2, 5.8) mg\/L], blood and sternal bone marrow aspirates (subset, n = 14) were collected at baseline and after 6 months of semaglutide \u22642.0\u2005mg weekly. Circulating monocytes and haematopoietic precursors were quantified by flow cytometry, plasma cytokines using an nELISA\u2122 assay (Nomic Bio) and inflammatory macrophages in coronary arteries, bone marrow, and spleen by gallium-68\u2013labelled DOTA-(Tyr3)-octreotate (68Ga-DOTATATE) positron emission tomography-computed tomography scans.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After 6 months of semaglutide, significant reductions in HbA1c (\u221221.1\u2005mmol\/mol, P &amp;lt; .0001), weight (\u22126.7\u2005kg, P &amp;lt; .001), BMI (\u22122.5\u2005kg\/m2, P &amp;lt; .001), and hsCRP (\u22121.0\u2005mg\/L, P = .005) were observed. Circulating CD16+ monocytes were markedly lower (\u221218.8%, P = .034), with increased bone marrow retention correlating with weight loss, alongside reductions in interleukin-1 receptor antagonist, leptin, E-selectin, intercellular adhesion molecule-1 (ICAM-1), C-C motif chemokine ligand 2, C-C motif chemokine ligand 11, and C-X-C motif chemokine ligand 13. Gallium-68\u2013labelled DOTA-(Tyr3)-octreotate PET-CT showed lower bone marrow uptake (\u221217.5%, P = .037), but not in spleen or coronary arteries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Semaglutide in T2D potentially reduces circulating inflammatory monocytes, increases bone marrow retention, and lowers markers of endothelial inflammation, with no reduction in coronary artery inflammatory macrophages. Semaglutide is associated with lower bone marrow 68Ga-DOTATATE uptake, which may relate to anti-inflammatory effects relevant to CVD risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehag627","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:13:55Z","timestamp":1785323635000},"source":"Crossref","is-referenced-by-count":0,"title":["Potential bone marrow\u2013driven reduction of circulating inflammatory monocytes by semaglutide in Type 2 diabetes"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0342-6037","authenticated-orcid":false,"given":"Charlotte J","family":"Teunis","sequence":"first","affiliation":[{"name":"Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam , Meibergdreef 9, Amsterdam 1105AZ ,","place":["the Netherlands"]},{"name":"Baker Heart and Diabetes Institute, Haematopoiesis and Leukocyte Biology , Melbourne ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8044-2815","authenticated-orcid":false,"given":"Thomas J C","family":"Collins","sequence":"additional","affiliation":[{"name":"Department of Experimental Vascular Medicine, Amsterdam UMC Location University of Amsterdam , Meibergdreef 9, Amsterdam ,","place":["The Netherlands"]},{"name":"Amsterdam Cardiovascular Sciences, Atherosclerosis & Aortic Disease , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reindert F","family":"Oostveen","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam , Meibergdreef 9, Amsterdam 1105AZ ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9029-3991","authenticated-orcid":false,"given":"Annette E","family":"Neele","sequence":"additional","affiliation":[{"name":"Amsterdam Cardiovascular Sciences, Atherosclerosis & Aortic Disease , Amsterdam ,","place":["The Netherlands"]},{"name":"Department of Medical Biochemistry, Amsterdam UMC, University of Amsterdam , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4038-6636","authenticated-orcid":false,"given":"Menno","family":"de Winther","sequence":"additional","affiliation":[{"name":"Amsterdam Cardiovascular Sciences, Atherosclerosis & Aortic Disease , Amsterdam ,","place":["The Netherlands"]},{"name":"Department of Medical Biochemistry, Amsterdam UMC, University of Amsterdam , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9045-6009","authenticated-orcid":false,"given":"Nick S","family":"Nurmohamed","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam , Meibergdreef 9, Amsterdam 1105AZ ,","place":["the Netherlands"]},{"name":"Amsterdam Cardiovascular Sciences, Atherosclerosis & Aortic Disease , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9615-7851","authenticated-orcid":false,"given":"Jarom","family":"Heijmans","sequence":"additional","affiliation":[{"name":"Department of Haematology, Amsterdam UMC, University of Amsterdam , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike","family":"Winkelmeijer","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam , Meibergdreef 9, Amsterdam 1105AZ ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4867-818X","authenticated-orcid":false,"given":"Kim E","family":"Dzobo","sequence":"additional","affiliation":[{"name":"Department of Experimental Vascular Medicine, Amsterdam UMC Location University of Amsterdam , Meibergdreef 9, Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7785-2488","authenticated-orcid":false,"given":"Mark E","family":"Cooper","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Monash University , Melbourne ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2894-6124","authenticated-orcid":false,"given":"Dani\u00ebl H","family":"van Raalte","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam , Meibergdreef 9, Amsterdam 1105AZ ,","place":["the Netherlands"]},{"name":"Diabeter Centrum Amsterdam , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1926-7659","authenticated-orcid":false,"given":"Max","family":"Nieuwdorp","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam , Meibergdreef 9, Amsterdam 1105AZ ,","place":["the Netherlands"]},{"name":"Diabeter Centrum Amsterdam , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hein J","family":"Verberne","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7584-7677","authenticated-orcid":false,"given":"Erik S G","family":"Stroes","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam , Meibergdreef 9, Amsterdam 1105AZ ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7039-7777","authenticated-orcid":false,"given":"Andrew J","family":"Murphy","sequence":"additional","affiliation":[{"name":"Baker Heart and Diabetes Institute, Haematopoiesis and Leukocyte Biology , Melbourne ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9983-6614","authenticated-orcid":false,"given":"Jeffrey","family":"Kroon","sequence":"additional","affiliation":[{"name":"Department of Experimental Vascular Medicine, Amsterdam UMC Location University of Amsterdam , Meibergdreef 9, Amsterdam ,","place":["The Netherlands"]},{"name":"Amsterdam Cardiovascular Sciences, Atherosclerosis & Aortic Disease , Amsterdam ,","place":["The Netherlands"]},{"name":"Amsterdam Institute for Immunology and Infectious Diseases , Amsterdam ,","place":["The Netherlands"]},{"name":"Laboratory of Angiogenesis and Vascular Metabolism, VIB-KU Leuven Center for Cancer Biology, VIB , Leuven ,","place":["Belgium"]},{"name":"Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI) , Leuven ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9541-7244","authenticated-orcid":false,"given":"Nordin M J","family":"Hanssen","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam , Meibergdreef 9, Amsterdam 1105AZ ,","place":["the Netherlands"]},{"name":"Amsterdam Cardiovascular Sciences, Atherosclerosis & Aortic Disease , Amsterdam ,","place":["The Netherlands"]},{"name":"Diabeter Centrum Amsterdam , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"2026092902362784100_ehag627-B1","doi-asserted-by":"publisher","first-page":"846","DOI":"10.2337\/dc25-0241","article-title":"Cardiovascular and kidney outcomes and mortality with long-acting injectable and oral glucagon-like peptide 1 receptor agonists in individuals with type 2 diabetes: a systematic review and meta-analysis of randomized trials","volume":"48","author":"Lee","year":"2025","journal-title":"Diabetes Care"},{"key":"2026092902362784100_ehag627-B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101737","article-title":"Effects of once-weekly semaglutide 2.4 mg on C-reactive protein in adults with overweight or obesity (STEP 1, 2, and 3): exploratory analyses of three randomised, double-blind, placebo-controlled, phase 3 trials","volume":"55","author":"Verma","year":"2023","journal-title":"EClinicalMedicine"},{"key":"2026092902362784100_ehag627-B3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1001\/jama.2009.954","article-title":"Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease","volume":"302","author":"Elliott","year":"2009","journal-title":"JAMA"},{"key":"2026092902362784100_ehag627-B4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d548","article-title":"Association between C reactive protein and coronary heart disease: Mendelian randomisation analysis based on individual participant data","volume":"342","author":"C Reactive Protein Coronary Heart Disease Genetics Collaboration (CCGC)","year":"2011","journal-title":"BMJ"},{"key":"2026092902362784100_ehag627-B5","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"2026092902362784100_ehag627-B6","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"2026092902362784100_ehag627-B7","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1161\/ATVBAHA.124.319851","article-title":"Colchicine's role in cardiovascular disease management","volume":"44","author":"Buckley","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026092902362784100_ehag627-B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102956","article-title":"Effects of tumour necrosis factor on cardiovascular disease and cancer: a two-sample Mendelian randomization study","volume":"59","author":"Yuan","year":"2020","journal-title":"EBioMedicine"},{"key":"2026092902362784100_ehag627-B9","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1517\/14656566.9.7.1121","article-title":"Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs","volume":"9","author":"Avouac","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"2026092902362784100_ehag627-B10","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.kint.2023.09.029","article-title":"Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products-induced inflammation","volume":"105","author":"Sourris","year":"2024","journal-title":"Kidney Int"},{"key":"2026092902362784100_ehag627-B11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI194751","article-title":"Antiinflammatory actions of glucagon-like peptide-1-based therapies beyond metabolic benefits","volume":"135","author":"Wong","year":"2025","journal-title":"J Clin Invest"},{"key":"2026092902362784100_ehag627-B12","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.570553","article-title":"Postprandial glucose spikes, an important contributor to cardiovascular disease in diabetes?","volume":"7","author":"Hanssen","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"2026092902362784100_ehag627-B13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"key":"2026092902362784100_ehag627-B14","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1161\/CIRCRESAHA.120.316653","article-title":"Transient intermittent hyperglycemia accelerates atherosclerosis by promoting myelopoiesis","volume":"127","author":"Flynn","year":"2020","journal-title":"Circ Res"},{"key":"2026092902362784100_ehag627-B15","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1093\/eurheartj\/ehab465","article-title":"Impact of cholesterol on proinflammatory monocyte production by the bone marrow","volume":"42","author":"Stiekema","year":"2021","journal-title":"Eur Heart J"},{"key":"2026092902362784100_ehag627-B16","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"2026092902362784100_ehag627-B17","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1007\/s00125-023-05990-9","article-title":"Atorvastatin lowers (68)Ga-DOTATATE uptake in coronary arteries, bone marrow and spleen in individuals with type 2 diabetes","volume":"66","author":"Oostveen","year":"2023","journal-title":"Diabetologia"},{"key":"2026092902362784100_ehag627-B18","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.jacc.2012.07.019","article-title":"CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography","volume":"60","author":"Rogacev","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026092902362784100_ehag627-B19","doi-asserted-by":"publisher","DOI":"10.1177\/09636897241226546","article-title":"Effect of high BMI on human bone marrow-derived mesenchymal stromal cells","volume":"33","author":"Zong","year":"2024","journal-title":"Cell Transplant"},{"key":"2026092902362784100_ehag627-B20","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1089\/ten.TEA.2009.0346","article-title":"Body mass index is more predictive of progenitor number in bone marrow stromal cell population than age in men: expanding the predictors of the progenitor compartment","volume":"16","author":"McCann","year":"2010","journal-title":"Tissue Eng Part A"},{"key":"2026092902362784100_ehag627-B21","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.3390\/jcm11144169","article-title":"Correlation of body mass index and proinflammatory cytokine levels with hematopoietic stem cell mobilization","volume":"11","author":"Wang","year":"2022","journal-title":"J Clin Med"},{"key":"2026092902362784100_ehag627-B22","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1038\/oby.2010.347","article-title":"Influence of BMI on level of circulating progenitor cells","volume":"19","author":"Bellows","year":"2011","journal-title":"Obesity (Silver Spring)"},{"key":"2026092902362784100_ehag627-B23","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/j.jacc.2017.01.060","article-title":"Detection of atherosclerotic inflammation by (68)Ga-DOTATATE PET compared to [(18)F]FDG PET imaging","volume":"69","author":"Tarkin","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026092902362784100_ehag627-B24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ahj.2025.05.001","article-title":"Effect of once-weekly subcutaneous semaglutide on arterial inflammation in people with type 2 diabetes and cardiovascular disease using PET-MRI: primary results of a randomized, double-blind, placebo-controlled trial","volume":"289","author":"James","year":"2025","journal-title":"Am Heart J"},{"key":"2026092902362784100_ehag627-B25","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.hjc.2018.11.008","article-title":"GLP-1 receptor agonists and cardiovascular outcome trials: an update","volume":"60","author":"Andrikou","year":"2019","journal-title":"Hellenic J Cardiol"},{"key":"2026092902362784100_ehag627-B26","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.88238","article-title":"Effect of statin therapy on clinical outcomes in patients with cardiovascular risks: a systematic review and meta-analysis","volume":"17","author":"Ghani Khan","year":"2025","journal-title":"Cureus"},{"key":"2026092902362784100_ehag627-B27","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.cmet.2013.04.001","article-title":"Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis","volume":"17","author":"Nagareddy","year":"2013","journal-title":"Cell Metab"},{"key":"2026092902362784100_ehag627-B28","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S2213-8587(14)70160-3","article-title":"Is there a diminishing return of prior glycaemic control?","volume":"2","author":"Hanssen","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026092902362784100_ehag627-B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2025.106645","article-title":"Association of glucagon-like peptide-1 receptor agonist use with risk of infections: a systematic review and meta-analysis","volume":"91","author":"Han","year":"2025","journal-title":"J Infect"},{"key":"2026092902362784100_ehag627-B30","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1093\/eurheartj\/ehaf289","article-title":"Acute coronary syndromes: mechanisms, challenges, and new opportunities","volume":"46","author":"Kraler","year":"2025","journal-title":"Eur Heart J"},{"key":"2026092902362784100_ehag627-B31","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1038\/nm.3258","article-title":"Local proliferation dominates lesional macrophage accumulation in atherosclerosis","volume":"19","author":"Robbins","year":"2013","journal-title":"Nat Med"},{"key":"2026092902362784100_ehag627-B32","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1161\/CIRCULATIONAHA.110.955302","article-title":"High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study","volume":"122","author":"Ferrante","year":"2010","journal-title":"Circulation"},{"key":"2026092902362784100_ehag627-B33","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.7150\/ijbs.4989","article-title":"IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6","volume":"8","author":"Rose-John","year":"2012","journal-title":"Int J Biol Sci"},{"key":"2026092902362784100_ehag627-B34","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/S2213-8587(25)00197-4","article-title":"Beyond a singular focus on GLP-1: why we need a new nomenclature now","volume":"13","author":"Muskiet","year":"2025","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article-pdf\/doi\/10.1093\/eurheartj\/ehag627\/71455886\/ehag627.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article-pdf\/doi\/10.1093\/eurheartj\/ehag627\/71455886\/ehag627.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:36:34Z","timestamp":1790663794000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article\/doi\/10.1093\/eurheartj\/ehag627\/8843749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":34,"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehag627","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"article-number":"ehag627"}}